Protein restriction during pregnancy affects maternal liver lipid metabolism and fetal brain lipid composition in the rat.
Suboptimal developmental environments program offspring to lifelong metabolic problems. The aim of this study was to determine the impact of protein restriction in pregnancy on maternal liver lipid metabolism at 19 days of gestation (dG) and its effect on fetal brain development. Control (C) and restricted (R) mothers were fed with isocaloric diets containing 20 and 10% of casein. At 19 dG, maternal blood and livers and fetal livers and brains were collected. Serum insulin and leptin levels were determinate in mothers. Maternal and fetal liver lipid and fetal brain lipid quantification were performed. Maternal liver and fetal brain fatty acids were quantified by gas chromatography. In mothers, liver desaturase and elongase mRNAs were measured by RT-PCR. Maternal body and liver weights were similar in both groups. However, fat body composition, including liver lipids, was lower in R mothers. A higher fasting insulin at 19 dG in the R group was observed (C = 0.2 +/- 0.04 vs. R = 0.9 +/- 0.16 ng/ml, P < 0.01) and was inversely related to early growth retardation. Serum leptin in R mothers was significantly higher than that observed in C rats (C = 5 +/- 0.1 vs. R = 7 +/- 0.7 ng/ml, P < 0.05). In addition, protein restriction significantly reduced gene expression in maternal liver of desaturases and elongases and the concentration of arachidonic (AA) and docosahexanoic (DHA) acids. In fetus from R mothers, a low body weight (C = 3 +/- 0.3 vs. R = 2 +/- 0.1 g, P < 0.05), as well as liver and brain lipids, including the content of DHA in the brain, was reduced. This study showed that protein restriction during pregnancy may negatively impact normal fetal brain development by changes in maternal lipid metabolism.
Torres
Nimbe
N
Departamento de Fisiologia de la Nutricion, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico City, Mexico.
Bautista
Claudia J
CJ
Tovar
Armando R
AR
Ordáz
Guillermo
G
Rodríguez-Cruz
Maricela
M
Ortiz
Victor
V
Granados
Omar
O
Nathanielsz
Peter W
PW
Larrea
Fernando
F
Zambrano
Elena
E
D000821:Animal Feed; D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D001921:Brain / Q000196:embryology* / Q000378:metabolism; D001923:Brain Chemistry; D018753:Diet, Protein-Restricted; D004041:Dietary Fats / Q000378:metabolism; D004281:Docosahexaenoic Acids / Q000378:metabolism*; D005260:Female; D047109:Fetal Development / Q000502:physiology; D050356:Lipid Metabolism / Q000502:physiology; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000378:metabolism*; D039382:Maternal Nutritional Physiological Phenomena; D008431:Maternal-Fetal Exchange / Q000502:physiology; D011247:Pregnancy; D011488:Protein Deficiency / Q000150:complications / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
D004041:Dietary Fats; D008055:Lipids; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid